Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$110.6b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.8b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Axsome Therapeutics

Market Cap: US$12.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

ALTEOGEN

Market Cap: ₩19.5t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Akeso

Market Cap: HK$107.4b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Ionis Pharmaceuticals

Market Cap: US$12.5b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Royalty Pharma

Market Cap: US$30.8b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Alnylam Pharmaceuticals

Market Cap: US$40.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Ascendis Pharma

Market Cap: US$15.4b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

Neurocrine Biosciences

Market Cap: US$15.6b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Insmed

Market Cap: US$23.7b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

argenx

Market Cap: €43.6b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

BridgeBio Pharma

Market Cap: US$13.8b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

Torrent Pharmaceuticals

Market Cap: ₹1.5t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Viatris

Market Cap: US$19.2b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

AstraZeneca

Market Cap: UK£215.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Chugai Pharmaceutical

Market Cap: JP¥13.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Innovent Biologics

Market Cap: HK$140.5b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Galderma Group

Market Cap: CHF 37.2b

Operates as a dermatology company worldwide.

Sartorius Stedim Biotech

Market Cap: €16.6b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Merck

Market Cap: US$286.2b

Operates as a healthcare company worldwide.

AbbVie

Market Cap: US$379.0b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Jazz Pharmaceuticals

Market Cap: US$15.0b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BeOne Medicines

Market Cap: US$34.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 152.7b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Waters

Market Cap: US$33.5b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Gilead Sciences

Market Cap: US$162.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.4b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Natera

Market Cap: US$29.2b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Sandoz Group

Market Cap: CHF 27.9b

Develops, manufactures, and markets generic and biosimilars worldwide.

Novartis

Market Cap: CHF 227.9b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Sino Biopharmaceutical

Market Cap: HK$93.1b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Daiichi Sankyo Company

Market Cap: JP¥4.8t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Orion Oyj

Market Cap: €10.0b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Divi's Laboratories

Market Cap: ₹1.8t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Eurofins Scientific

Market Cap: €11.0b

Provides various analytical testing and laboratory services worldwide.